Vertex Receives CHMP Positive Opinion for ALYFTREK®, a New Once-Daily CFTR Modulator for the Treatment of Cystic Fibrosis
-
28/02/2025, 07:05
-
ansa.it
0
Scopri altro
- oggi, 01:02
-
repubblica.it
-
0
- oggi, 00:16
-
repubblica.it
-
0
- 28/04/2025, 08:05
-
ansa.it
-
0
- 28/04/2025, 08:05
-
ansa.it
-
0
- 28/04/2025, 08:02
-
ansa.it
-
0
- 28/04/2025, 07:43
-
ansa.it
-
0
- 28/04/2025, 06:34
-
ansa.it
-
0
- 27/04/2025, 16:52
-
money.it
-
0
- 27/04/2025, 15:59
-
ansa.it
-
0
Nessun commento